Physician profile
Wendy Cutler
NPI 1417922741
$24,614.54
in general payments reported to CMS, 2019-2025
44 companies · $523 in 2025
The $523 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,390 · 2021: $522 · 2022: $554 · 2023: $654 · 2024: $672 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,750.00 | 2019-2020 | |
| Pfizer INC. | $544.56 | 2019-2024 | |
| Abbvie INC. | $493.97 | 2019-2023 | Lo Loestrin Fe |
| Shield Therapeutics INC | $300.56 | 2022-2024 | Accrufer |
| Astellas Pharma US INC | $260.58 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $186.92 | 2021-2022 | |
| Exeltis, USA INC. | $184.00 | 2019-2024 | Slynd |
| Coopersurgical, INC. | $159.78 | 2019-2025 | Paragard T 380a, Summit Doppler |
| Hologic Sales and Service, LLC | $148.96 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay, Myosure Tissue Removal Device, Aptima |
| Medtronic, INC. | $118.56 | 2025 | Ligasure |
| Sumitomo Pharma America, INC. | $116.95 | 2024-2025 | Myfembree, Gemtesa |
| Roche Diagnostics Corporation | $110.47 | 2019-2020 | |
| Coloplast Corp | $93.83 | 2023-2024 | Altis |
| Merck Sharp & Dohme LLC | $85.43 | 2019-2025 | Gardasil 9 |
| Organon LLC | $80.18 | 2022-2025 | Nexplanon |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Cutler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.